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Memory is the storage of information over time (McGaugh, 2000). Some of these bits of information can be highly similar or even overlapping. 
To be able to distinguish between overlapping information, the brain uses pattern separation, which is commonly defined as the ability to form 
separate representations from highly similar, yet slightly different events or stimuli (Yassa & Stark, 2011). Pattern separation occurs in the 
dentate gyrus (DG), a subregion of the hippocampus (Dillon et al., 2017; Yassa & Stark, 2011). Deficits in this process are among the first and 
most severe symptoms observed during aging and in disorders characterized by memory dysfunction such as Alzheimer's disease, post-trau-
matic stress disorder, and schizophrenia.
Hippocampus-dependent memory formation is promoted by sleep and disrupted by sleep deprivation (SD; Abel, Havekes, Saletin, & 
Walker, 2013; Kreutzmann, Havekes, Abel, & Meerlo, 2015). The negative impact of SD on hippocampal function is at least partly caused by 
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Abstract
Sleep deprivation (SD) is known to impair hippocampus-dependent memory processes, 
in part by stimulating the phosphodiesterase (PDE) activity. In the present study, we 
assessed in mice whether SD also affects spatial pattern separation, a cognitive pro-
cess that specifically requires the dentate gyrus (DG) subregion of the hippocampus. 
Adult male mice were trained in an object pattern separation (OPS) task in the mid-
dle of the light phase and then tested 24 hr thereafter. In total, we conducted three 
studies using the OPS task. In the first study, we validated the occurrence of pattern 
separation and tested the effects of SD. We found that 6 hr of SD during the first half 
of the light phase directly preceding the test trial impaired the spatial pattern separa-
tion performance. As a next step, we assessed in two consecutive studies whether the 
observed SD-induced performance deficits could be prevented by the systemic appli-
cation of two different PDE inhibitors that are approved for human use. Both the PDE4 
inhibitor roflumilast and PDE5 inhibitor vardenafil successfully prevented SD-induced 
deficits in spatial pattern separation. As a result, these PDE inhibitors have clinical po-
tential for the prevention of memory deficits associated with loss of sleep.
K E Y W O R D S
dentate gyrus, memory, pattern separation, roflumilast, sleep deprivation, sleep disorders, 
vardenafil
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increased phosphodiesterase (PDE) activity and related suppression of cAMP signaling (Havekes et al., 2014; Havekes, Park, Tolentino, et al., 
2016; Vecsey et al., 2009). Because cGMP and cAMP signaling potentially target the same downstream signaling molecules known to be af-
fected by SD (i.e., CREB (Wong, Tann, Ibanez, & Sajikumar, 2019), LIMK1-cofilin (Havekes, Park, Tudor, et al., 2016; Wong et al., 2019; Zulauf 
et al., 2009)), cGMP signaling may also be a relevant therapeutic target in this respect. While disrupting effects of SD have been reported for a 
variety of hippocampal tasks (Havekes & Abel, 2017; Havekes, Meerlo, & Abel, 2015), its impact on pattern separation remains to be defined.
The latter becomes even more interesting as neuronal connectivity in the DG itself is disrupted by sleep loss (Meerlo, Mistlberger, Jacobs, 
Heller,	&	McGinty,	2009;	Raven,	Meerlo,	Van	der	Zee,	Abel,	&	Havekes,	2018).	Moreover,	sleep	loss	is	a	common	feature	of	the	aforemen-
tioned disorders characterized by deficits in pattern separation (e.g., Kheirbek, Klemenhagen, Sahay, & Hen, 2012; Van Erum, Van Dam, & De 
Deyn,	2019;	van	Goethem,	van	Hagen,	&	Prickaerts,	2018;	van	Os	&	Kapur,	2009).
Therefore, the first aim of the current study was to investigate the effect of SD in a well-validated mouse model for spatial pattern sep-
aration. To this end, 12 male 57BL/6J mice (Charles River) were ordered at 6 weeks of age and pair-housed. One week before the start of 
the	experiments	when	the	animals	were	8–16	weeks	old,	animals	were	individually	housed.	The	experimental	room	was	kept	under	constant	
temperature	(22°)	and	a	12	h	light/12	h	dark	cycle	(lights	on	9:00–21:00).	Poly	carb	clear	cages	with	a	stainless	steel	wired	lid	were	provided	
with nesting material, cardboard rolls, and sawdust bedding. Chow diet and water were available ad libitum. All procedures were approved 
by	the	national	Central	Authority	for	Scientific	Procedures	on	Animals	(CCD)	and	the	Institutional	Animal	Welfare	Body	(IvD,	University	of	
Groningen,	The	Netherlands),	and	conform	Directive	2010/63/EU.	Prior	to	the	studies,	the	animals	were	handled	daily	for	3	days,	adapted	to	
the procedures, and allowed to explore the empty arena for 5 min on 2 separate days.
We	first	confirmed	the	occurrence	of	spatial	pattern	separation	with	the	object	pattern	separation	(OPS)	task	(Figure	1a).	The	OPS	task	is	
a novel, translational spatial pattern separation paradigm highly sensitive to cognitive impairment and extensively described elsewhere (van 
Goethem	et	al.,	2018).	Briefly,	the	OPS	paradigm	consists	of	two	trials.	During	the	learning	trial	(T1),	the	rectangular	arena	contains	two	identical	
objects	placed	(and	oriented)	symmetrically	on	a	horizontal	line,	in	which	the	mouse	is	allowed	to	explore	for	10	min	(Figure	1a).	The	arena	is	made	
of PVC and has a length of 40 cm, width of 30 cm, and height of 50 cm high. The four walls of the arena consist of grey colored PVC and the bottom 
consists	of	transparent	PVC.	Four	pairs	of	two	identical	objects	are	used.	These	objects	are	either	two	blue	aluminum	cylinders	(height	12	cm	and	
diameter 3.5 cm), two orange aluminum cylinders with tapering tops (height 12 cm and diameter at widest point 3.5 cm), two green glass cylinders 
(height 12 cm and diameter 2.5 cm), or two pink round vases (height 10 cm and diameter ranging from 3.5 cm at the bottom to 1.5 at the top). 
Inside the arena, two spatial cues are presented at opposite sides at the short walls of the rectangular arena. One cue consists of black and white 
F I G U R E  1   (a) Spatial pattern separation performance (d2 values as mean + SEM) as measured with the OPS test (24 h interval; # 
represents significant difference from zero (## = p < .01, ### = p < .001) by independent samples t test; * indicates a significant difference 
from position 1 (** = p < .01, *** = p < .001, and * = p = .051, by paired samples t test; N = 12). (b) Six hours of SD at the beginning of the light 
phase directly preceding T2 impairs spatial pattern separation performance in the OPS (position 3; 24 h interval; # represents a significant 
difference from zero (### = p < .001), by independent samples t test; * represents a significant difference between NSD and SD (** = p < .01) 
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striping, while the other cue consists of a black and white checkerboard pattern. After a 24 hr interval, mice are placed back in the apparatus for 
the test trial of 10 min (T2). During T2, one of the two similar objects is randomly displaced along a straight line on one of the five possible loca-
tions in either direction according to the randomization and location scheme. In other words, during T2, mice are confronted with a new spatial 
arrangement. The distance between two adjacent positions is always 3.75 cm. This means that during the test trial (T2) the object is moved 0 cm 
for position 1; 1 × 3.75 cm for position 2; 2 × 3.75 cm for position 3; 3 × 3.75 cm for position 4; 4 × 3.75 cm for position 5. All positions are 7.5 cm 




In line with previous work, we showed that reducing the moved distance of the relocated object (position 5 to 1) decreases the discrimination 
score	(d2),	indicating	that	the	task	became	increasingly	difficult	(Figure	1).	Position	3	showed	to	be	the	minimal	distinguishable	distance	(different	
from	zero	(chance	level)	but	not	from	position	1),	which	suggests	a	maximal	DG	activation	(van	Goethem	et	al.,	2018;	van	Goethem,	Schreiber,	
Newman-Tancredi, Varney, & Prickaerts, 2015). The latter is important, as this position truly requires pattern separation and not merely spatial 
memory (a point often overlooked in rodent studies). As a result, position 3 was used during the test trial (T2) in the consecutive studies.
As	a	next	step,	we	tested	the	effects	of	SD	on	spatial	pattern	separation	(Figure	1b).	Mice	were	trained	6	hr	into	the	light	phase	and	left	un-
disturbed	for	approximately	18	hr.	Thereafter,	mice	were	kept	awake	for	6	hr	at	the	beginning	of	the	light	phase	when	sleep	pressure	is	highest	
and directly preceding the test trial (T2). The latter was done to maximize the effect of SD on pattern separation as, in the current setup, during 
T2 the new information (i.e., the relocation of one object) has to be integrated and properly distinguished from the old information (i.e., original 
object position during T1). SD before or after T1 (as commonly observed in most other mnemonic and sleep studies (e.g., (Havekes, Park, Tudor, 
et al., 2016)) would affect the acquisition and consolidation of the old information. This can affect subsequent pattern separation during T2, 
but would not directly test the effect of SD on spatial pattern separation itself. Mice were sleep deprived using the gentle stimulation method 
as described previously (Havekes, Park, Tudor, et al., 2016). Importantly, we did not use any objects, cages, clean bedding, or other arousing 
stimuli to keep the animals awake to avoid confounding effects of arousal during SD. This SD method has been validated previously using EEG 
recordings (Meerlo, de Bruin, Strijkstra, & Daan, 2001). Six hours of SD directly preceding T2, impaired spatial pattern separation performance 
(Figure	1b).	This	finding	is	in	line	with	recent	findings	in	humans	that	sleep	promotes	pattern	separation	(Hanert,	Weber,	Pedersen,	Born,	&	
Bartsch, 2017). Importantly, we observed no differences in total object exploration times when comparing T1 and T2 within experimental 
conditions or when comparing T1 or T2 exploration times between experimental conditions (p > .05 in all cases, data not shown). The latter 
analyses indicated that the observed deficits in pattern separation were not due to a total decrease in the explorative activity.
In our previous studies, we showed that the suppression of PDE function prevents memory deficits caused by sleep loss (Havekes, Park, Tudor, 
et al., 2016; Vecsey et al., 2009). Therefore, as a next step, we assessed whether the pharmacological inhibition of PDE activity makes pattern sep-
aration resilient to sleep loss. Importantly, we inhibited PDE activity systemically using drugs that are approved for human use, thereby increasing 
the	translational	value	of	the	study	(Baillie,	Tejeda,	&	Kelly,	2019;	Heckman,	Blokland,	Bollen,	&	Prickaerts,	2018;	Heckman,	Wouters,	&	Prickaerts,	
2015).	The	following	two	FDA-approved	PDE	inhibitors	were	used:	the	PDE4	inhibitor	roflumilast	(Sigma	Aldrich,	Zwijndrecht,	the	Netherlands)	
and the PDE5 inhibitor vardenafil (kindly donated by BAYER, Wuppertal, Germany). Both PDE inhibitors were previously shown to cross the 
blood–brain	barrier	(Akkerman,	Blokland,	&	Prickaerts,	2016;	Vanmierlo	et	al.,	2016).	We	dissolved	both	drugs	daily	in	the	same	vehicle	solution	
(98%	methyl	cellulose	tylose	solution	(0.5%)	and	2%	Tween80)	and	administered	them	in	a	volume	of	2	ml/kg.	The	drugs	were	administered	i.p. at 
the start and 3 hr into SD at a dose of 0.03 mg/kg for roflumilast and 0.3 mg/kg for vardenafil. Dosages, volumes, and injection schemes are based 
on our extensive experience with the current drugs (e.g., Akkerman et al., 2016; Vanmierlo et al., 2016; Vecsey et al., 2009).
First,	we	focused	on	the	cAMP	signaling	pathway	using	the	PDE4	inhibitor	roflumilast,	which	improves	the	hippocampal	memory	function	
in animal models as well as young and old human volunteers (Blokland et al., 2019; Van Duinen et al., 2017; Vanmierlo et al., 2016). The sys-
temic	delivery	of	roflumilast	during	SD	successfully	prevented	the	impairment	in	spatial	pattern	separation	(Figure	2).	Importantly,	roflumilast	
exerts its effect at a dose lacking the characteristic emetic side effects observed with classical PDE4 inhibitors (Vanmierlo et al., 2016).
Because cGMP and cAMP signaling potentially target the same downstream signaling molecules known to be affected by SD (i.e., CREB 
(Wong et al., 2019), LIMK1-cofilin (Havekes, Park, Tudor, et al., 2016)), as a next step we targeted cGMP signaling using the PDE5 inhibitor 
vardenafil. Vardenafil has previously shown to increase cGMP in the hippocampus and improve the memory function in rodents (Akkerman 
et	al.,	2016).	Treatment	with	vardenafil	also	made	the	pattern	separation	process	resilient	to	SD	(Figure	3).
Together, these results indicate that the inhibition of, respectively, PDE4 or PDE5 signaling with systemic drugs during SD is sufficient to 
prevent the SD-induced deficits in spatial pattern separation. A statistical difference between the two PDE inhibitors is that the upregulation 
of cAMP specifically counters the detrimental effect of SD (interaction effect; Havekes et al., 2014; Havekes, Park, Tudor, et al., 2016; Vecsey 
et al., 2009), whereas the upregulation of cGMP leads to a general cognition-enhancing effect (main effect; Akkerman et al., 2016; Argyrousi 
et al., 2019). However, this difference can be explained by the larger negative discrimination value after SD in the vehicle treatment condition 
of the roflumilast experiment and may not be a real difference in effect between the PDE inhibitors on the effect of SD on pattern separation. 
Of note, for the latter, neither any post hoc statistical evidence was found. Altogether, the outcome of these studies makes both inhibitors 
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interesting from a therapeutic perspective as both treatments seem to protect the memory process against the mechanisms by which SD 
impairs spatial pattern separation.
Previous work has shown that SD decreases CREB phosphorylation in the DG and in parallel upregulates the levels of PDE4A5 in total 
hippocampal lysates resulting in attenuated levels of cAMP and impaired consolidation of context fear and spatial memories (Havekes, Park, 
Tolentino, et al., 2016; Vecsey et al., 2009). Decreased levels of hippocampal cAMP negatively impact neuronal connectivity through cAMP-
PKA-LIMK-cofilin signaling and attenuating PDE4A5 function prevents these changes including the aforementioned spatial memory deficits 
(Havekes, Park, Tolentino, et al., 2016; Havekes, Park, Tudor, et al., 2016). Similar changes in neuronal connectivity have been observed in the 
DG	after	SD	(Raven	et	al.,	2018).	In	future	studies,	it	will,	therefore,	be	interesting	to	examine	whether	the	impairments	in	the	OPS	are	a	direct	
result of increased PDE4A5 function specifically in the DG. The latter would provide functional insight into the molecular underpinnings by 
which the administration of roflumilast may exert its effect under the conditions of SD.
The role of cGMP and its downstream effectors in spatial pattern separation is currently unknown and to our knowledge, no studies have 
examined the impact of SD on cGMP signaling in this respect. However, both cyclic nucleotide pathways are known to converge on the CREB 
and LIMK1-cofilin pathways (Havekes, Park, Tudor, et al., 2016; Wong et al., 2019; Zulauf et al., 2009), known to play a causal role in the 
memory	and	plasticity	phenotypes	associated	with	SD.	For	this	reason,	it	may	very	well	be	that	treatment	with	vardenafil	prevents	deficits	in	
patterns’ separation by acting on the aforementioned signaling pathways.
Finally,	it	should	be	noted	that	both	inhibitors	did	not	improve	spatial	pattern	separation	in	the	non-SD	condition.	The	main	reason	for	the	
lack of effect on normal (non-SD) pattern separation could be related to the time of injection as well as the concentration used. In addition, 
levels of cAMP in non-SD mice must be higher relative to SD mice. Indeed, in our previous work, we showed that SD reduces basal cAMP levels 
in the hippocampus (Vecsey et al., 2009). The same may be the cause for cGMP levels although to our knowledge no studies have compared 
these levels under SD and non-SD conditions. As such, these higher cAMP levels and potentially higher cGMP levels in non-SD mice may also 
contribute to the lack of an effect of PDE4/PDE5 inhibition in non-SD animals.
In summary, we have demonstrated for the first time that SD negatively impacts spatial pattern separation. As the DG is the main brain 
area related to spatial pattern separation and specific roles of the cAMP and cGMP pathways in memory processes have been previously 
described,	we	tested	whether	the	SD-induced	impairment	in	spatial	pattern	separation	could	be	avoided	by	the	application	of	FDA-approved	
F I G U R E  2   Six hours of SD at the beginning of the light phase directly preceding T2 impairs spatial pattern separation performance 
(d2 values as mean + SEM) as measured with the OPS test (position 3; 24 h interval). A two-factor repeated measures ANOVA, using 
Sleep Deprivation (non-sleep deprived, sleep deprived) and Treatment (vehicle, roflumilast) as within subject factors, showed a significant 
interaction effect (F(1,11)	=	9.784,	p = .010; N = 12). Subsequent post hoc test of simple effects showed that vehicle-treated SD animals 
different from all three other experimental conditions (** = p < .01; N = 12; paired samples t test including Bonferroni correction), indicating 
that roflumilast protects against SD-induced deficits in spatial pattern separation. # represents a significant difference from zero (# = p < .05, 
## = p < .01; N = 12) using independent samples t test. OPS = spatial object pattern separation task; PDE4-I = phosphodiesterase type 4 
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PDE inhibitors. Both the PDE4 inhibitor roflumilast and PDE5 inhibitor vardenafil successfully prevented SD-induced deficits in spatial pat-
tern	separation,	suggesting	that	these	two	FDA-approved	pharmacological	inhibitors	may	be	suited	to	combat	the	negative	impact	of	SD	on	
cognitive processes.
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